MX368381B - Derivados de n-acilhidrazona para inhibidor selectivo de celulas t y farmacos anti malignidad linfoide. - Google Patents
Derivados de n-acilhidrazona para inhibidor selectivo de celulas t y farmacos anti malignidad linfoide.Info
- Publication number
- MX368381B MX368381B MX2015002601A MX2015002601A MX368381B MX 368381 B MX368381 B MX 368381B MX 2015002601 A MX2015002601 A MX 2015002601A MX 2015002601 A MX2015002601 A MX 2015002601A MX 368381 B MX368381 B MX 368381B
- Authority
- MX
- Mexico
- Prior art keywords
- selective
- acylhydrazone derivatives
- lymphoid malignancy
- cell inhibitor
- novel
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000000237 anti-lymphoid effect Effects 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 230000036210 malignancy Effects 0.000 title abstract 2
- 101000935814 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) Periplasmic beta-glucosidase Proteins 0.000 title 1
- 229940123155 T cell inhibitor Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120095729 | 2012-08-30 | ||
| KR20120108972 | 2012-09-28 | ||
| PCT/KR2013/007751 WO2014035149A1 (en) | 2012-08-30 | 2013-08-29 | N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015002601A MX2015002601A (es) | 2015-09-29 |
| MX368381B true MX368381B (es) | 2019-09-30 |
Family
ID=50183887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015002601A MX368381B (es) | 2012-08-30 | 2013-08-29 | Derivados de n-acilhidrazona para inhibidor selectivo de celulas t y farmacos anti malignidad linfoide. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9447083B2 (OSRAM) |
| EP (1) | EP2890677B1 (OSRAM) |
| JP (1) | JP6139682B2 (OSRAM) |
| KR (1) | KR101561987B1 (OSRAM) |
| CN (1) | CN104755460B (OSRAM) |
| AU (1) | AU2013309723B2 (OSRAM) |
| BR (1) | BR112015004432A2 (OSRAM) |
| CA (1) | CA2881797C (OSRAM) |
| ES (1) | ES2651312T3 (OSRAM) |
| IN (1) | IN2015MN00411A (OSRAM) |
| MX (1) | MX368381B (OSRAM) |
| NZ (1) | NZ704807A (OSRAM) |
| PH (1) | PH12015500282B1 (OSRAM) |
| RU (1) | RU2622651C2 (OSRAM) |
| WO (1) | WO2014035149A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106986789B (zh) * | 2016-01-20 | 2019-07-16 | 中国人民解放军军事医学科学院生物医学分析中心 | 对苯二酚类化合物及其制备方法与在抗肿瘤或免疫调节中的应用 |
| EP3851519A4 (en) * | 2018-09-28 | 2021-12-29 | Nissan Chemical Corporation | Additive for medium for promoting production of paracrine factor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
| DE102004037515A1 (de) | 2003-08-22 | 2005-03-17 | Merck Patent Gmbh | Verfahren zur Herstellung von Aldehyden |
| EP1885361A2 (en) * | 2005-05-06 | 2008-02-13 | Boehringer Ingelheim International GmbH | Acyl hydrazones for treating cardiovascular diseases |
| US8283351B2 (en) * | 2007-04-02 | 2012-10-09 | Institute For Oneworld Health | Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof |
| US8642660B2 (en) | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009155362A1 (en) * | 2008-06-19 | 2009-12-23 | Ligand Pharmaceuticals Inc. | Small molecule hematopoietic growth factor mimetic compounds and their uses |
| WO2013032907A1 (en) | 2011-08-26 | 2013-03-07 | The Broad Institute, Inc. | Compounds and methods for the treatment of cancer stem cells |
-
2013
- 2013-08-29 WO PCT/KR2013/007751 patent/WO2014035149A1/en not_active Ceased
- 2013-08-29 US US14/424,749 patent/US9447083B2/en not_active Expired - Fee Related
- 2013-08-29 NZ NZ704807A patent/NZ704807A/en not_active IP Right Cessation
- 2013-08-29 AU AU2013309723A patent/AU2013309723B2/en not_active Ceased
- 2013-08-29 EP EP13833207.7A patent/EP2890677B1/en not_active Not-in-force
- 2013-08-29 RU RU2015105511A patent/RU2622651C2/ru active
- 2013-08-29 JP JP2015529676A patent/JP6139682B2/ja not_active Expired - Fee Related
- 2013-08-29 ES ES13833207.7T patent/ES2651312T3/es active Active
- 2013-08-29 IN IN411MUN2015 patent/IN2015MN00411A/en unknown
- 2013-08-29 CN CN201380056385.7A patent/CN104755460B/zh not_active Expired - Fee Related
- 2013-08-29 MX MX2015002601A patent/MX368381B/es active IP Right Grant
- 2013-08-29 BR BR112015004432A patent/BR112015004432A2/pt not_active Application Discontinuation
- 2013-08-29 CA CA2881797A patent/CA2881797C/en not_active Expired - Fee Related
- 2013-08-30 KR KR1020130103747A patent/KR101561987B1/ko not_active Expired - Fee Related
-
2015
- 2015-02-09 PH PH12015500282A patent/PH12015500282B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140029318A (ko) | 2014-03-10 |
| JP6139682B2 (ja) | 2017-05-31 |
| PH12015500282A1 (en) | 2015-04-27 |
| KR101561987B1 (ko) | 2015-10-20 |
| EP2890677A4 (en) | 2016-03-09 |
| US9447083B2 (en) | 2016-09-20 |
| RU2015105511A (ru) | 2016-10-20 |
| PH12015500282B1 (en) | 2015-04-27 |
| CN104755460A (zh) | 2015-07-01 |
| MX2015002601A (es) | 2015-09-29 |
| EP2890677A1 (en) | 2015-07-08 |
| IN2015MN00411A (OSRAM) | 2015-09-04 |
| NZ704807A (en) | 2016-06-24 |
| CN104755460B (zh) | 2017-05-10 |
| AU2013309723B2 (en) | 2016-07-14 |
| RU2622651C2 (ru) | 2017-06-19 |
| BR112015004432A2 (pt) | 2017-07-04 |
| WO2014035149A1 (en) | 2014-03-06 |
| EP2890677B1 (en) | 2017-11-15 |
| CA2881797A1 (en) | 2014-03-06 |
| CA2881797C (en) | 2017-08-01 |
| AU2013309723A1 (en) | 2015-02-26 |
| ES2651312T3 (es) | 2018-01-25 |
| US20150252030A1 (en) | 2015-09-10 |
| JP2015526508A (ja) | 2015-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
| MX2015012850A (es) | Inhibidores de la arginina metiltransferasa y usos de los mismos. | |
| IN2014DN09434A (OSRAM) | ||
| MD20170016A2 (ro) | Compuşi aminopirimidinici ca inhibitori JAK | |
| MY199894A (en) | Prmt5 inhibitors and uses thereof | |
| IN2015DN01156A (OSRAM) | ||
| MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
| NZ762034A (en) | Human plasma kallikrein inhibitors | |
| JO3115B1 (ar) | مركبات بيريدازينون واستخدامها كمثبطات daao | |
| MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
| PH12013501600A1 (en) | Novel heterocyclic derivatives | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
| PH12015500376A1 (en) | Novel bicyclic pyridinones | |
| PH12015501088A1 (en) | Dimeric compounds | |
| GB201209587D0 (en) | Therapeutic compounds | |
| TW201613864A (en) | Novel compounds | |
| NZ727188A (en) | Aldosterone synthase inhibitors | |
| WO2014062838A3 (en) | Pkm2 modulators and methods for their use | |
| MX2016003522A (es) | Derivados de quinazolinas y su uso como inhibidores de la adn metiltransferasa. | |
| PH12015500111A1 (en) | Difluorolactam compositions for ep4-mediated osteo related diseases and conditions | |
| PH12015500399A1 (en) | Azaindolines | |
| PH12015500185B1 (en) | Azaheterocycles as bir2 and/or bir3 inhibitors | |
| MD20160111A2 (ro) | Derivaţi diheterociclici legaţi de cicloalchil |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |